Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 26, Issue 1, Pages 139-146Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.intimp.2015.03.016
Keywords
Interleukin-27; IL-27p28; Inflammation; Virus infection; Anti-tumor immunity
Categories
Funding
- National Natural Science Foundation of China [81201607]
- Scientifical Fund for Outstanding People of Hebei Province [H2014206320]
- Postdoctoral Fund of China [2013M540883]
Ask authors/readers for more resources
Interleukin (IL)-27 is an important pleiotropic immunological regulator for having dual effects on the immune responses. Several distinct findings have been highlighted that in certain conditions, neutralizing IL-27 or its subunit IL-27p28 might be a useful strategy to limit inflammation. Recently more insights have revealed that IL-27 could also exert potent inhibitory functions in some other immune circumstances including virus infection and tumor immunity. In this review, we describe IL-27 receptor subunits and the mechanisms of individual IL-27, and summarize the advances of their preclinical application trials. In addition, the potential role of IL-27 as a clinical therapeutic target will also be discussed. (C) 2015 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available